Flecainide versus ibutilide for immediate cardioversion of atrial fibrillation of recent onset

被引:84
作者
Reisinger, J
Gatterer, E
Lang, W
Vanicek, T
Eisserer, G
Bachleitner, T
Niemeth, C
Aicher, F
Grander, W
Heinze, G
Kühn, P
Siostrzonek, P
机构
[1] Krankenhaus Barmherzige Schwestern, Dept Internal Med Cardiol, A-4020 Linz, Austria
[2] Krankenanstalt Rudolfstiftung Wien, Dept Internal Med Cardiol, Vienna, Austria
[3] Krankenhaus Sierning, Dept Internal Med, Sierning, Austria
[4] Krankenhaus Braunau, Dept Internal Med, Braunau, Austria
[5] Krankenhaus Barmherzige Schwestern, Dept Internal Med, Ried, Austria
[6] Landeskrankenhaus Enns, Dept Internal Med, Enns, Austria
[7] Bezirkskrankenhaus Hall Tirol, Dept Internal Med, Tyrol, Austria
[8] Univ Vienna, Dept Med Comp Sci, Sect Clin Biometr, A-1010 Vienna, Austria
关键词
atrial fibrillation; cardioversion; flecainide; ibutilide;
D O I
10.1016/j.ehj.2004.04.030
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims This study compared the efficacy and safety of intravenous flecainide and ibutilide for immediate cardioversion of atrial. fibrillation (AF). Methods and results We conducted a prospective, randomised trial, including 207 patients with AF of recent onset (less than or equal to 48 h). Flecainide was given over 20 min at a dose of 2 mg/kg body weight (maximum 200 mg), ibutilide was infused at a dose of 1 mg (or 0.01 mg/kg if less than 60 kg) over 10 min, followed by a 10 min observation period and an identical second dose if AF did not convert to sinus rhythm (SR). Treatment was considered successful if SR occurred within 90 min of starting medication. The conversion rates were 56.4% in patients given flecainide and 50.0% in patients given ibutilide (P = 0.34). Multivariate analysis revealed that a lower age for women independently increased the probability of conversion. None of the other variables, including left atrial, size, left ventricular systolic function, presence of left ventricular hypertrophy, plasma levels of potassium or magnesium at baseline, or concomitant use of digoxin, beta-blocker, diltiazem or verapamil were predictors of conversion. The frequency of adverse events was comparable in the two treatment groups. Conclusions There was no significant difference in the cardioversion efficacy or in the risk of adverse events between flecainide and ibutilide in patients with AF of recent onset. In patients without contraindications to both medications, the physician's choice has to be governed by other factors. (C) 2004 Published by Elsevier Ltd on behalf of The European Society of Cardiology.
引用
收藏
页码:1318 / 1324
页数:7
相关论文
共 36 条
[1]   Electrophysiologic mechanisms of perpetuation of atrial fibrillation [J].
Allessie, MA ;
Konings, K ;
Kirchhof, CJHJ ;
Wijffels, M .
AMERICAN JOURNAL OF CARDIOLOGY, 1996, 77 (03) :A10-A23
[2]   Subgroup analysis and other (mis)uses of baseline data in clinical trials [J].
Assmann, SF ;
Pocock, SJ ;
Enos, LE ;
Kasten, LE .
LANCET, 2000, 355 (9209) :1064-1069
[3]   FLECAINIDE VERSUS QUINIDINE FOR CONVERSION OF ATRIAL-FIBRILLATION TO SINUS RHYTHM [J].
BORGEAT, A ;
GOY, JJ ;
MAENDLY, R ;
KAUFMANN, U ;
GRBIC, M ;
SIGWART, U .
AMERICAN JOURNAL OF CARDIOLOGY, 1986, 58 (06) :496-498
[4]  
DONOVAN KD, 1995, AM J CARDIOL, V75, P693, DOI 10.1016/S0002-9149(99)80655-9
[5]   REVERSION OF RECENT-ONSET ATRIAL-FIBRILLATION TO SINUS RHYTHM BY INTRAVENOUS FLECAINIDE [J].
DONOVAN, KD ;
DOBB, GJ ;
COOMBS, LJ ;
LEE, KY ;
WEEKES, JN ;
MURDOCK, CJ ;
CLARKE, GM .
AMERICAN JOURNAL OF CARDIOLOGY, 1991, 67 (02) :137-141
[6]  
Dunn AB, 2000, ANN PHARMACOTHER, V34, P1233
[7]   Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: A dose-response study [J].
Ellenbogen, KA ;
Stambler, BS ;
Wood, MA ;
Sager, PT ;
Wesley, RC ;
Meissner, MD ;
Zoble, RG ;
Wakefield, LK ;
Perry, KT ;
Vanderlugt, JT .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 28 (01) :130-136
[8]   FLECAINIDE [J].
FALK, RH ;
FOGEL, RI .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 1994, 5 (11) :964-981
[9]   RATE-CORRECTED QT INTERVAL - TECHNIQUES AND LIMITATIONS [J].
FUNCKBRENTANO, C ;
JAILLON, P .
AMERICAN JOURNAL OF CARDIOLOGY, 1993, 72 (06) :B17-B22
[10]  
Glatter K, 2001, CIRCULATION, V103, P253